Search

27 May 2017 Research Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.

27 May 2017 - 13:45

SATVI author Associate Professor Tom Scriba has co-authored a paper titled "Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial" appearing in the American Journal of Respiratory and Critical Care

View abstract.